
Medical interest in Germany has increased in the necessity of taking into account biological and social differences in diagnosing and treating diseases between the sexes.
Medical research on 'gender-sensitive medicine' is increasing in Germany, as studies have shown that symptoms of diseases, such as heart attacks, may differ between women and men, necessitating changing diagnostic and treatment standards to ensure accurate healthcare.
AI-generated summary
Historically, medical diagnostic and treatment standards have been based on data from male patients, ignoring biological and social differences in women.
For many years, medicine has treated the human body as if the differences between women and men were limited primarily to the reproductive organs. But recent medical research shows that differences can extend to disease symptoms, risk factors, and response to some treatments, making what is known as “gender-sensitive medicine” receiving increasing attention.
According to the German magazine "Bild der Frau", certain diseases affect women only, while other diseases appear in them in different proportions or symptoms, which can affect the speed of discovering the disease and the method of treating it.
Heart attack..is it different?
The most prominent examples are heart disease. The common picture of a heart attack is associated with severe and sudden chest pain, but the matter may be less clear in some women.
According to the German Heart Foundation Deutsche Herzstiftung, the symptoms of a heart attack in some women may be less clear, especially in older women, and can include shortness of breath, nausea, sweating, dizziness, and back or upper abdominal pain, which may sometimes lead to delayed diagnosis.
This trend is reinforced by what the German Heart Center at Charite Hospital in Berlin announced in May 2026, when it launched a special initiative for women’s heart health, stressing that cardiovascular diseases represent a major cause of death among women, and that many diagnostic and treatment standards have historically been based more on data from male patients.
The heart is not alone
The differences are not limited to heart disease. The German Ministry of Health indicates that women and men may differ in terms of risk factors and the spread of some diseases, and differences may also appear in prevention, diagnosis, treatment, and even the effect of some medications.
Special stages of a woman's life, such as pregnancy and menopause, also affect health risks. Social and psychological factors and how to deal with pressure and stress also play a role, in addition to biological factors.
One of the conditions that receive special attention among women is what is known as “broken heart syndrome” or “Takotsubo syndrome,” which is a real disorder of the heart muscle and not just a metaphorical description of sadness, and it appears more frequently in women, especially after menopause.
German law has its say
Taking into account the differences between women and men is no longer just an academic discussion in Germany. Since 2015, the German Health Insurance Act stipulates that gender-related characteristics must be taken into account when providing health services, in a move aimed at incorporating the results of research related to women's and men's health more into prevention, diagnosis, and health care.
In 2026, the German Ministry of Health also allocated more space for research into women's health, stressing that the impact of gender differences has long been insufficiently represented in medical research.
Different medicine or more precise medicine?
Gender-sensitive medicine does not mean that women and men always need different treatments, or that every woman will have different symptoms from men.
The basic idea is that the male body should not be viewed as the only medical model, and that differences should not be ignored when they are important for diagnosis, prevention or treatment selection.
Thus, calling for medical “equality” between women and men does not mean providing better care to one at the expense of the other, but rather recognizing that care of equal quality may sometimes need to be treated differently with different bodies.

Recent scientific reports address a new experimental drug called CBL-514 that causes fat cells to self-destruct, a simple method of boiling water to remove plastic particles, in addition to a study confirming the benefits of brown fat in preventing diseases.

Southeast Asia faces toxic smog from fires in Indonesia, while Bangladesh suffers a massive measles outbreak that has killed more than 1,100 people, amid challenges in reaching children and declining vaccination coverage.

Bangladesh is battling the world's worst measles outbreak, with 202,000 suspected cases and 1,147 deaths, the majority of them children, due to declining vaccination coverage, weak data and limited awareness efforts.

Bangladesh is battling the world's worst measles outbreak, with 202,000 suspected cases and 1,147 deaths recorded, amid declining vaccination coverage and data gaps, while controversy arose over the qualifications of White House spokeswoman Katie Zakaria after her comments about China.

Lung cancer is the number one cancer killer in America, surpassing the number of victims of the prostate, colon, and breast. Despite the advancement of early detection techniques such as low-dose CT scanning and artificial intelligence, misconceptions and inadequate screening guidelines deprive many people of early diagnosis.

Recent medical studies have revealed a potential role for the drug cabergoline in reducing the risk of breast cancer after childbirth, and the importance of warm milk for women during menopause, in addition to the association of caffeine consumption in children with brain changes and behavioral problems.